The report on the Liquid Biopsy Market published by Stratview Research covers in depth details associated with the Liquid Biopsy Market. This report is Segmented by Products Services Type (Assay Kits, Instruments, and Services), by Application Type (Cancer {Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, and Others} and Non-Cancer), by Clinical Application Type (Therapy Selection, Treatment Monitoring, Recurrence Monitoring, and Early Cancer Screening), by Circulating Biomarkers Type (Circulating Tumor Cells, Cell-Free DNA, Circulating Tumor DNA, Extracellular Vesicles, and Others), by Technology Type (Multi-Gene Parallel Analysis Using NGS and Single-Gene Analysis Using PCR Microarrays), by End-User Type (Reference Laboratories, Hospitals and Physician Laboratories, Academic Research Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).

The report states that the Liquid Biopsy Market was estimated at USD 2.4 billion in 2021 and is expected to grow at a CAGR of 18% during 2022-2028 to reach USD 7.64 billion in 2028.

What is a liquid biopsy?

Liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, mainly blood. This technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive.

COVID-19 IMPACT

The impact of the global pandemic Covid-19 was felt across all industries in every field. However, the liquid biopsy market managed to escape the pandemic with minimum damage. The liquid biopsy market witnessed a slight decline in the year 2020 during the pandemic and is likely to rebound at a healthy rate in the forecast period.

Key Players

The following are the key players in the aerospace sheet distribution market:

• Biocept Inc.
• Bio-Rad Laboratories
• F. Hoffmann-La Roche Ltd.
• Guardant Health Inc.
• Illumina, Inc.
• Johnson Johnson
• Laboratory Corporation of America Holdings
• MDxHealth SA
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.

How stakeholders will profit from this report?

This report allows an understanding of the market and benefits from any lucrative opportunities that are available. The market experts have offered a comprehensive study of the existing market scenario while concentrating on the new business objectives. Below given are some reasons why stakeholders should invest in this report -

Market Size Forecasts: The authors of the report have provided a precise evaluation of the Liquid Biopsy Market size based on value and volume.

Market Trend Analysis: This segment of the report throws light on the present and upcoming trends and developments in the Liquid Biopsy Market.

Risk Factors Growth drivers: The report here offers crucial information on the rewarding opportunities, growth drivers, and risk factors in the Liquid Biopsy Market.

About Us

Stratview Research is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful and actionable market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more. Stratview Research helps its users tract the ever-evolving market scenarios through its top-notch market reports.

Get in touch with us at – sales@stratviewresearch.com.

Or connect with our experts at +1-313-307-4176